Showing posts with label Investment Research. Show all posts
Showing posts with label Investment Research. Show all posts

Goldman Sachs S&P 500 Target: Is 8,000 Actually Reachable?

Smart Investor Research is on NewsLens
Read all 22 AI channels in one free app
stock market trading screen monitors - Financial stock market data displayed on a screen.

Photo by Daniel Brzdęk on Unsplash

As of June 16, 2026, Goldman Sachs' revised S&P 500 year-end target of 8,000 sits roughly 5.9% above where the index traded on June 15 — close enough to generate real optimism, far enough to require the earnings story to keep delivering without a single meaningful stumble.

The Thesis — One Falsifiable Claim

14.2 percentage points. That's the average annual gap between Wall Street's S&P 500 forecast and the index's actual return, measured across 25 years from 2000 through 2024. Google News, citing original reporting by MarketBeat on June 16, 2026, flagged Goldman Sachs' revised 8,000 year-end target in the context of a fresh mid-year rally — a figure that investors are watching with equal parts conviction and hard-earned historical skepticism.

Thesis: Goldman's S&P 500 target of 8,000 is defensible only if AI-driven earnings deliver 24% EPS growth (earnings per share, meaning profit divided by total shares outstanding) in 2026 — the moment that growth narrative cracks, the index's CAPE ratio of 42.5 (a long-term valuation metric that compares current stock prices to 10 years of inflation-adjusted earnings) has no structural floor to fall back on.

On May 27, 2026, Goldman Sachs raised its year-end S&P 500 price objective from 7,600 to 8,000, representing a potential 6.4% gain from the index's level of 7,519 at the time of the revision. Bloomberg reported that the move aligned Goldman with Morgan Stanley and Deutsche Bank, both of which had already staked the same 8,000 endpoint — a consensus implying a 17% total return for the S&P 500 across all of 2026. CNBC, meanwhile, distilled Goldman's rationale to a single driver: earnings. The index has since hit a record closing high of 7,609.78 in early June 2026, before settling at 7,554.29 as of June 15 — leaving roughly 6% still separating the current level from Goldman's target.

The Evidence — What the Earnings Data Actually Shows

Goldman's case rests on a specific quantitative claim. The firm raised its 2026 S&P 500 earnings-per-share forecast to $340, representing 24% year-over-year growth, and projects $385 EPS for 2027 — a deceleration to 13% growth as the AI investment wave matures. Ben Snider, Goldman's chief US equity strategist, stated directly: "Earnings growth has powered the entire S&P 500 return so far this year, and we expect this dynamic to continue in the coming months."

FactSet data adds quarterly texture to that headline number. Analysts project year-over-year earnings growth of 21.0% for calendar year 2026 in aggregate, with Q3 2026 and Q4 2026 expected to run particularly hot — at 25.3% and 22.8% year-over-year growth, respectively. If those back-half numbers land, the year-end earnings story will have justified valuations that currently look stretched by almost any historical measure.

S&P 500 Year-End 2026 Targets by Firm Bank of America 7,100 JPMorgan (base) 7,600 Goldman / MS / DB 8,000 Citigroup 8,100 Current: 7,554 (Jun 15, 2026)

Chart: Wall Street S&P 500 year-end 2026 price targets, ranging from Bank of America's contrarian 7,100 to Citigroup's 8,100 bull case. Scale runs 6,500–8,500; bar widths are proportional. The dashed line marks the index's closing level of 7,554.29 on June 15, 2026.

The valuation warning runs on two tracks simultaneously. The S&P 500's CAPE ratio stands at 42.5 — a level historically associated with extended bull market peaks, not sustainable rallies. Separately, the index trades at roughly 21 times forward earnings (the price paid today for estimated next-year profits), leaving almost no cushion for earnings misses without triggering multiple compression (where investors lower what they are willing to pay per dollar of earnings, compounding any revenue shortfall). David Kostin, Goldman's former chief US equity strategist, framed this tension clearly in October 2025: "Earnings, rather than valuations, represent the primary uncertainty surrounding our forecast." That concession matters. It signals that the valuation case is already fully extended, and the entire path to 8,000 runs through earnings delivery — nothing else.

Wall Street's divergence on targets reflects a genuine analytical disagreement, not just noise. Citigroup's Scott Chronert raised his year-end price target to 8,100, projecting S&P 500 earnings could reach $350 per share aided by what he calls an AI "supercycle." JPMorgan lifted its base-case forecast from 7,200 to 7,600, with a blue-sky scenario of 8,000 contingent on the Federal Reserve continuing to cut interest rates throughout 2026. Bank of America set a contrarian lower target of 7,100, citing "too many red flags" including valuation risks, geopolitical uncertainty, and index concentration. State Street's Michael Arone offered the cleanest bull-case framing, stating that "The S&P 500 could surge to 8,000 by the end of 2026" driven by AI adoption and corporate efficiency gains.

S&P 500 financial chart data terminal - stock market candlestick chart on dark screen

Photo by Maxim Hopman on Unsplash

AI as the Engine: $670 Billion in Committed Capex

Goldman's bullish revision is inseparable from the artificial intelligence infrastructure spending cycle. AI investment is expected to account for approximately 50% of S&P 500 earnings growth in 2026, according to Goldman's own analysis. The anchor figure behind that claim: the largest cloud computing companies have collectively planned to spend an estimated $670 billion this year on AI infrastructure — a level of committed capital expenditure with few peacetime parallels in modern corporate history.

This is where sector analysis connects directly to index-level investment research. The $670 billion in capex flows through the income statements of semiconductor manufacturers, data center operators, power infrastructure companies, and cloud platforms — each link in a supply chain that shows up in S&P 500 aggregate earnings. SpaceX's IPO debut on June 12, 2026 at $135 per share also contributed to Goldman's raised earnings forecast through increased IPO activity and broader market participation — a signal that the capital formation environment remains active. Smart Finance AI's recent breakdown of the SpaceX IPO and what the market rally signals offers a useful parallel read on how major capital events are feeding Goldman's broader earnings thesis.

The concentration risk embedded in all of this deserves explicit attention. The Magnificent Seven tech stocks — Apple, Microsoft, Nvidia, Alphabet, Amazon, Meta, and Tesla — represent approximately one-third of the S&P 500's total market cap. The 10 largest companies in the index now comprise more than 41% of its total value. David Kelly, Chief Global Strategist at J.P. Morgan Asset Management, has explicitly flagged this dynamic, warning that the current market setup "looks similar to 1999" — a year that ended at what proved to be the index's generational peak before a multi-year decline.

The Bear Case Deserves Better Than a Paragraph

Prediction markets on Kalshi, as of June 2026, assigned a 26.3% probability that the S&P 500 will reach 8,000 or above by year-end. That is not a fringe scenario — but it also means the market's collective assessment gives Goldman's target roughly a one-in-four shot at being right on the number. The bear case is not paranoia; it deserves honest arithmetic.

Three specific risks stand out in this stock analysis. First, valuation compression: at a CAPE ratio of 42.5 and 21 times forward earnings, any meaningful earnings disappointment in Q3 or Q4 2026 would trigger multiple contraction on top of the earnings miss itself — the downside is structurally asymmetric. Second, concentration fragility: with the 10 largest companies comprising more than 41% of the index, a rotation out of mega-cap tech — triggered by regulatory action, competitive disruption, or simply profit-taking — could drag the entire index even if smaller-cap earnings outperform. Third, the forecast track record itself: over 25 years ending in 2024, Wall Street's average yearly S&P 500 forecast missed the actual return by 14.2 percentage points. Goldman's 8,000 figure is a thesis with a time stamp, not a commitment.

Bank of America's 7,100 target — the lowest of the major banks covered in this analysis — reflects a coherent analytical position rather than reflexive contrarianism. The argument is that index concentration, elevated valuations, and geopolitical uncertainty together create a downside risk profile that the AI earnings narrative does not fully offset. That view deserves equal analytical weight in any serious market trends assessment, even when the broader consensus tilts higher.

Watchlist — What to Track Before December

For investors conducting their own investment research on S&P 500 market trends, these are the specific metrics and dates worth tracking:

  1. Q2 2026 earnings season (July–August 2026): Goldman's $340 full-year EPS forecast requires the back half to carry substantial weight. Q2 results will be the first real stress test of whether AI infrastructure spending is translating into top-line revenue at the expected pace, rather than just generating capital expenditure outflows.
  2. Cloud capex guidance from hyperscalers: The estimated $670 billion in AI infrastructure spending is only meaningful if quarterly earnings calls from Amazon (AMZN), Microsoft (MSFT), Alphabet (GOOGL), and Meta (META) confirm the spending trajectory. Any guidance reduction from a major hyperscaler would stress Goldman's AI earnings thesis at its foundation.
  3. CAPE ratio movement: Watch whether the current 42.5 reading expands further or begins to compress. A sustained move toward 45+ without a commensurate earnings beat signals that valuation risk is intensifying faster than the bull case can absorb.
  4. Earnings concentration within the Magnificent Seven: Track what share of S&P 500 Q2 and Q3 earnings growth is attributable to the seven largest companies. If that figure surpasses 50%, the "broad earnings recovery" narrative supporting Goldman's forecast loses significant credibility.
  5. Federal Reserve rate path: JPMorgan's blue-sky 8,000 scenario is explicitly contingent on continued Fed rate cuts throughout 2026. Any pause or policy reversal would simultaneously compress both the valuation multiple and the earnings growth rate that Goldman's forecast depends on.

In my analysis, the October 2026 Q3 earnings season is the clearest single falsification test in this entire debate. Goldman projects 25.3% year-over-year earnings growth for Q3 2026 — the largest quarterly leap in the full-year forecast. When I look at that number against the 42.5 CAPE ratio and the 26.3% prediction-market probability for hitting 8,000, I'd hold that October print as the pivot point. If Q3 earnings come in at 18% or below, the 8,000 target becomes a 2027 conversation. Every confident year-end call should be held loosely until that data arrives.

Frequently Asked Questions

What is Goldman Sachs' S&P 500 target for 2026, and what does it assume about earnings growth?

As of May 27, 2026, Goldman Sachs raised its S&P 500 year-end price objective to 8,000, up from a prior forecast of 7,600 — representing a potential 6.4% gain from the index's level of 7,519 at the time of the announcement. The revised forecast rests on a 2026 earnings-per-share projection of $340, representing 24% year-over-year growth, with AI infrastructure investment expected to contribute approximately 50% of that earnings expansion. Goldman also projects 2027 EPS of $385, implying a deceleration to 13% growth as the AI investment cycle matures.

Why is Goldman Sachs bullish on the S&P 500, and how does the AI spending cycle factor into the forecast?

Goldman's bullish stance is grounded entirely in earnings growth rather than valuation expansion. The firm projects 24% year-over-year EPS growth for 2026, with AI infrastructure spending as the primary engine. The largest cloud computing companies have planned approximately $670 billion in AI-related capital expenditures for 2026 — spending Goldman argues flows directly into earnings for semiconductor companies, data center operators, and cloud platforms that represent a disproportionate share of S&P 500 weight. The key risk is that capex and earnings are distinct metrics: if AI monetization lags the investment cycle, the earnings growth that justifies a 21x forward P/E multiple (price divided by next-year earnings estimates) could fall short. Bank of America's contrarian 7,100 target exists precisely because that lag risk is not currently priced into valuations.

How accurate are Wall Street S&P 500 predictions historically, and what do prediction markets say about the 8,000 target?

Wall Street's track record on annual S&P 500 forecasts is notably imprecise. Over the 25-year period from 2000 through 2024, the average yearly forecast missed the actual market return by 14.2 percentage points — a gap that underscores the difficulty of price-target precision even with sophisticated quantitative models. As of June 2026, prediction markets on Kalshi assigned a 26.3% probability that the S&P 500 will reach 8,000 or above by year-end — roughly a one-in-four chance. Goldman's target is worth researching as a framework for understanding the earnings and valuation environment, but the index's 42.5 CAPE ratio and 21x forward P/E leave little margin if the growth story disappoints even modestly.

Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security. Always do your own research and consult a licensed financial advisor before making investment decisions. Research based on publicly available sources current as of June 16, 2026.

Barrick and Constellation Energy Earnings Beats: Investment Research Breakdown

Smart Investor Research is on NewsLens
Read all 22 AI channels in one free app

Barrick and Constellation Energy Q1 2026 Earnings Beats: Investment Research Breakdown

stock market earnings investment research charts - text

Photo by Hennie Stander on Unsplash

Key Takeaways
  • Barrick Mining (NYSE: B) crushed Q1 2026 estimates with adjusted EPS of $0.98 — a 21% beat — on revenue of $5.22 billion, up 67% year-over-year, as record gold prices supercharged free cash flow.
  • Constellation Energy (NASDAQ: CEG) topped adjusted EPS estimates with $2.74, reported $11.12 billion in revenue, and maintained its full-year 2026 guidance of $11–$12 per share following its $16.4 billion Calpine acquisition.
  • Both beats reflect powerful macro tailwinds: gold prices near record highs are amplifying miner margins, while surging AI-driven electricity demand is reshaping the power sector.
  • Constellation CEO Joe Dominguez called the Calpine merger a "one-stop shop for the global data economy," signaling aggressive positioning for long-term co-location deals with hyperscale data centers.

What Happened

On May 11, 2026, two very different companies — a gold miner and a power generator — delivered earnings that sent their stocks higher and gave investors a fresh look at two of the market's hottest macro themes: commodity prices and AI-driven energy demand.

Barrick Mining (NYSE: B) reported first-quarter 2026 adjusted earnings per share (EPS — the company's profit divided by the number of shares outstanding) of $0.98, beating Wall Street's consensus estimate of $0.81 by a wide 21% margin. Revenue came in at $5.22 billion, up a stunning 67% from $3.13 billion in the same quarter a year ago, easily clearing the analyst estimate of $4.84 billion. Gold production of 719,000 ounces topped Barrick's own guidance range of 640,000–680,000 ounces, with strong output from Nevada Gold Mines, Veladero in Argentina, and the ramp-up at Loulo-Gounkoto in West Africa. Shares rose roughly 3% on the day.

Constellation Energy (NASDAQ: CEG) reported Q1 2026 GAAP EPS of $4.49 and adjusted EPS of $2.74 on revenue of $11.12 billion — well ahead of the roughly $9 billion analysts had modeled and above the consensus adjusted EPS estimate of $2.56–$2.59. The company reaffirmed its full-year 2026 adjusted operating earnings guidance of $11–$12 per share. During the quarter, Constellation commissioned both the 105 MW Pastoria Solar Project and the 460 MW Pin Oak Creek Energy Center gas facility in ERCOT (the Texas power grid).

Together, these results illustrate how elevated commodity prices and the AI infrastructure buildout are creating real, measurable earnings power — and why both names are attracting serious investment research attention heading into the second half of 2026.

AI data center electricity power grid infrastructure - a lot of power lines that are next to a building

Photo by Chelaxy Designs on Unsplash

What the Data Tells Us

The numbers here are unusually clear, and a little context makes them even more striking.

Think of Barrick's business like a lemonade stand with mostly fixed costs. Whether lemons cost $1 or $3, you still need the same stand, the same staff, and the same equipment. But when the price of a glass of lemonade jumps dramatically, nearly every extra dollar of revenue drops straight to profit. That's called operating leverage — the ability to turn revenue growth into outsized earnings growth. Gold prices near record highs in early 2026 have done exactly that for Barrick. Net EPS surged 256% year-over-year, and adjusted EPS climbed 180% — not because the company became a fundamentally different business overnight, but because higher gold prices amplified margins across every mine in its portfolio. The company generated $2.55 billion in operating cash flow and $1.21 billion in attributable free cash flow in a single quarter, underscoring that these gains are showing up in real money, not just accounting entries. Analysts tracking the stock noted the Q1 beat demonstrated that elevated bullion prices are translating directly into free cash flow — a key concern heading into the print.

For Constellation Energy, the story is about transformation through acquisition. The company completed its $16.4 billion purchase of Calpine Corporation in January 2026, dramatically expanding its fleet of power plants and immediately boosting revenue — which surged to $11.12 billion from a far smaller base a year earlier. This kind of growth through acquisition can be difficult to evaluate from a pure stock analysis standpoint, because the revenue jump partly reflects a bigger company rather than purely organic improvement. That said, the maintained full-year guidance of $11–$12 per share in adjusted operating earnings signals management confidence that the integration is tracking as planned.

CEO Joe Dominguez framed the Calpine deal as building a "one-stop shop for the global data economy." That phrase is worth unpacking. Major technology companies building AI infrastructure need enormous, reliable, long-term power supply. Co-location deals — where a data center is built physically adjacent to a power plant to receive electricity directly, bypassing grid congestion — allow companies like Constellation to capture premium pricing and lock in long-duration contracts. The company already secured a 380 MW power agreement with data center operator CyrusOne for a Texas facility immediately following the Calpine close. This positions Constellation at the intersection of two of the decade's biggest market trends: energy security and AI infrastructure build-out.

Both results remind investors that macro context shapes earnings quality enormously. When commodity prices are elevated and a new structural source of demand is emerging, companies with the right assets and scale can deliver beats that feel almost inevitable in hindsight — but are far from guaranteed going forward. Understanding how durable these tailwinds are is the core challenge for anyone doing serious sector analysis in this space.

Key Companies and Supply Chain

These earnings reports don't exist in a vacuum. Understanding the broader supply chain and competitive landscape helps put the results in fuller context — and surfaces related names worth researching.

Barrick Mining (NYSE: B) — As one of the world's largest gold producers, Barrick sits at the top of the gold mining supply chain, controlling mines across Nevada, Argentina, and West Africa. Its 67% revenue jump and 21% EPS beat make it a central name in any gold-focused sector analysis heading into Q2 2026.

Newmont Corporation (NYSE: NEM) — The other global gold mining giant and Barrick's closest peer. Investors conducting stock analysis on Barrick routinely compare it with Newmont to understand relative valuation and cost efficiency. Both benefit from the same elevated gold price environment, though their mine portfolios and cost structures differ.

Constellation Energy (NASDAQ: CEG) — Now the largest clean energy producer in the United States following the Calpine acquisition. Its nuclear fleet provides carbon-free baseload power (steady, always-on electricity generation), while newly acquired gas assets like the 460 MW Pin Oak Creek facility provide flexible, dispatchable capacity — exactly what AI data centers requiring uninterrupted power demand. Constellation is increasingly central to the AI power supply chain.

CyrusOne — A major data center operator that signed a 380 MW direct power agreement with Constellation following the Calpine close. This deal illustrates a broader supply chain shift: large technology infrastructure companies are moving upstream to secure power directly from generators rather than relying solely on utility grids.

Vistra Corp (NYSE: VST) — Another large competitive power generator investors are watching in the same market trends context. Like Constellation, Vistra operates in deregulated power markets and has been flagged by analysts as a potential beneficiary of AI-driven electricity demand. Comparing Vistra's results alongside Constellation's offers a useful cross-check in sector analysis.

Investors conducting their own investment research on these themes may also find it worthwhile to examine uranium producers (which supply nuclear fuel), electricity transmission infrastructure companies, and grid-scale battery storage developers — all of whom occupy critical nodes in the broader energy supply chain that companies like Constellation depend on for long-term operations.

What Should You Do? 3 Action Steps

1. Read the Earnings Call Transcripts

Both companies' Q1 2026 earnings call transcripts are worth reading in full as a first step in any investment research process. CEO language matters — Joe Dominguez's "one-stop shop for the global data economy" framing at Constellation, and Barrick's commentary on production guidance for the remainder of 2026, offer meaningful clues about where management sees the business heading. Transcripts are typically available free on company investor relations pages within 24 hours of the call and are far more informative than headline numbers alone.

2. Stress-Test the Macro Drivers

Both beats are partly macro-driven, and data suggests macro tailwinds can reverse. For Barrick, the key question worth researching is how the company's cost structure — specifically its AISC, or all-in sustaining cost (the total cost to produce one ounce of gold, including mine overhead and capital spending) — holds up at lower gold prices. For Constellation, investors are watching whether AI co-location demand materializes into additional signed agreements beyond the CyrusOne deal, and whether the Calpine integration delivers the expected cost synergies. Modeling both companies at different commodity price and demand scenarios is a sound analytical discipline before drawing any conclusions.

3. Track Peer Results for Sector Analysis Context

Earnings season is an opportunity to compare. Watching how Newmont's Q1 results stack up against Barrick's, or how Vistra's power revenue compares to Constellation's, can reveal whether these beats are company-specific achievements or simply a rising tide lifting all boats. Conducting sector analysis across gold mining and competitive power generation simultaneously gives a much clearer picture of where the alpha (market-beating returns) is actually coming from. Investors are following these cross-sector comparisons closely as Q1 2026 reporting season progresses.

Frequently Asked Questions

Is Barrick Mining stock a good investment in 2026 given record gold prices?

That question is worth researching carefully rather than answering with a simple yes or no. Barrick's Q1 2026 results — a 21% EPS beat, 67% revenue growth to $5.22 billion, and $1.21 billion in free cash flow — demonstrate strong operating leverage to elevated gold prices. Analysts noted the 256% year-over-year jump in net EPS shows that high bullion prices are translating directly into cash generation. However, gold prices are volatile and can decline rapidly when macro conditions shift. Investors tracking this story should examine Barrick's all-in sustaining cost per ounce to understand how profitability would change if gold prices fell significantly from current levels. This is not financial advice — always consult a licensed advisor before making investment decisions.

Why did Constellation Energy stock rise after Q1 2026 earnings despite a complex $16.4 billion acquisition?

Constellation's positive stock reaction reflects several factors worth examining in any stock analysis. First, the adjusted EPS of $2.74 beat the consensus estimate of roughly $2.56–$2.59, signaling the Calpine integration is not disrupting near-term profitability. Second, the reaffirmed full-year 2026 guidance of $11–$12 per share gave investors confidence in management's visibility for the rest of the year. Third, the broader narrative around AI-driven electricity demand — illustrated by the 380 MW CyrusOne data center agreement — is resonating as a structural, long-term growth driver rather than a one-time catalyst. Data suggests the market is pricing in not just current results but the potential pipeline of future co-location deals.

How does the Calpine acquisition change Constellation Energy's long-term earnings and supply chain position?

The $16.4 billion Calpine deal, completed in January 2026, significantly expanded Constellation's generation fleet with natural gas assets in competitive power markets, most notably ERCOT (the Texas grid). In the near term, it drove revenue to $11.12 billion in Q1 2026 — a dramatic year-over-year increase. Long-term, CEO Joe Dominguez has positioned the combined company as a "one-stop shop for the global data economy," meaning Constellation can now offer AI data center operators a range of power solutions — nuclear, gas, and solar — from a single counterparty. This strengthens its supply chain positioning relative to peers who offer only one fuel type. Investors are watching whether this narrative converts into a steady pipeline of signed co-location agreements over the next 12–24 months.

What are the biggest risks to Barrick Mining's earnings outlook if gold prices fall in late 2026?

Gold price risk remains the dominant factor in any sector analysis of Barrick Mining. The company's 180% jump in adjusted EPS and 256% surge in net EPS in Q1 2026 were largely products of elevated bullion prices amplifying margins across its mine portfolio — the same operating leverage that works powerfully in the company's favor when prices rise can compress earnings quickly when prices fall. If gold retreated meaningfully from current levels, Barrick's revenue and free cash flow would shrink in proportion. Additional risks worth researching include capital expenditure requirements at ramp-up assets like Loulo-Gounkoto, geopolitical exposure in the countries where Barrick operates, and currency fluctuations that affect operating costs denominated in local currencies. These factors together shape the risk profile investors need to weigh against the upside case.

How are AI data centers driving electricity demand and benefiting power stocks like Constellation Energy in 2026?

This is one of the most consequential market trends worth tracking in 2026 and beyond. Training and running large AI models requires massive, continuous computing power — which translates directly into electricity consumption at a scale that is straining existing grid infrastructure. A large AI data center campus can consume as much electricity as a mid-sized city. Companies like Constellation, which operate large, reliable nuclear and gas fleets, are positioned to offer co-location deals — physically placing data centers adjacent to power plants to deliver electricity directly, bypassing grid bottlenecks and locking in long-term supply agreements. The 380 MW CyrusOne agreement announced following Constellation's Calpine close is an early, concrete example of this supply chain dynamic in action. Investors conducting investment research in this space are watching how many additional gigawatts of co-location capacity get contracted across the industry in 2026 as a key indicator of whether the AI power theme delivers durable earnings growth.

Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security. Always do your own research and consult a licensed financial advisor before making investment decisions.

3 Growth Stocks the Market Is Throwing Away — Investment Research Deep Dive

Smart Investor Research is on NewsLens
Read all 22 AI channels in one free app

3 Growth Stocks the Market Is Throwing Away in 2026 — Investment Research Deep Dive

stock market research investment opportunity bull bear - black and silver laptop computer

Photo by Tech Daily on Unsplash

Key Takeaways
  • ServiceNow (NOW) trades roughly 52% below its 52-week high of $211.48 despite reporting 22% revenue growth and raising full-year 2026 guidance — 32 Wall Street analysts maintain a Buy rating with a consensus price target implying ~47% upside.
  • Roblox (RBLX) crashed more than 18% on May 1, 2026, after a temporary user miss tied to mandatory age-verification, yet Q1 revenue surged 39% year-over-year and its 18–34 demographic is accelerating fast.
  • Boston Scientific (BSX) cut its full-year organic growth outlook to 6.5%–8%, but its WATCHMAN device still grew 19% organically and a pending acquisition sets up a stronger 2027 story.
  • Short-term market overreactions to fixable problems can create entry points worth researching — but always conduct your own due diligence before making any investment decision.

What Happened

Markets have a long history of punishing stocks first and asking questions later. In the spring of 2026, three well-known growth companies — ServiceNow (NOW), Roblox (RBLX), and Boston Scientific (BSX) — have each been hit by sharp sell-offs that left their share prices dramatically below recent highs.

ServiceNow, an enterprise software giant that automates IT and business workflows, now trades roughly 52% below its 52-week high of $211.48, hovering near $100 — even though the company just reported Q1 2026 total revenue of $3.77 billion, up 22% year-over-year, and promptly raised its full-year guidance. Roblox — the gaming and social platform beloved by Gen Z — plunged more than 18% on May 1, 2026, after daily active users came in at 132 million, missing Wall Street's expectation of 143.8 million. The culprit was a mandatory age-verification rollout that launched in January 2026 and temporarily slowed new user onboarding. Meanwhile, Boston Scientific saw its stock slide after the medical device company trimmed its full-year 2026 organic revenue growth outlook from 10%–11% down to 6.5%–8%, citing unexpected headwinds in two specific product lines.

On the surface, all three stories sound alarming. But a closer look at the underlying market trends reveals something different: businesses with strong fundamentals being punished for problems that may be entirely temporary. That is exactly the kind of situation that disciplined investment research is designed to uncover.

growth stocks data analysis financial chart - a computer screen with a bunch of data on it

Photo by 1981 Digital on Unsplash

What the Data Tells Us

Think of the stock market like a grocery store that occasionally puts premium items on a deep-discount shelf by mistake. The job of careful stock analysis is to figure out whether that discounted item is genuinely spoiled — or simply marked down because someone panicked. Here is what the numbers reveal about each of these three companies.

ServiceNow (NOW) is one of the most closely followed enterprise software names on Wall Street. In Q1 2026, the company reported subscription revenue of $3.67 billion — up 22% year-over-year — and raised its full-year 2026 subscription revenue guidance to $15.735 billion–$15.775 billion, representing 20.5%–21% constant-currency growth (meaning growth adjusted to strip out the distorting effects of foreign exchange rate changes). Gartner, the respected technology research firm, named ServiceNow one of only a handful of leaders in the Workplace Experience Application space for 2026. The company also closed 16 transactions worth more than $5 million in net new ACV (annual contract value — the yearly revenue locked in from new deals) in Q1 alone, nearly 80% growth year-over-year. It now counts 630 customers generating $5M+ ACV, up approximately 22% from a year ago. Goldman Sachs weighed in with a May 2026 research note stating that the artificial intelligence software sell-off was overdone and that enterprise SaaS (Software-as-a-Service — cloud-based subscription software) leaders with durable revenue streams and accelerating AI-driven demand, such as ServiceNow, were disproportionately punished relative to any change in their underlying fundamentals. The ServiceNow CFO reinforced this on the Q1 earnings call, noting the company exceeded the high end of its topline and profitability guidance metrics, grew free cash flow, and returned capital to shareholders while accelerating revenue growth to 22% year-over-year. With 32 Wall Street analysts maintaining a Buy rating and a consensus price target of approximately $146.75 — implying roughly 47% upside from current levels — this is a name investors are watching closely.

Roblox (RBLX) reported Q1 2026 revenue of $1.4 billion — up 39% year-over-year — and bookings (money committed by users but not yet fully recognized as revenue under accounting rules) of $1.7 billion, up 43%. Daily active users reached 132 million, up 34 million from a year ago. The miss versus the expected 143.8 million is entirely attributed to friction created by the January 2026 mandatory age-verification rollout. Critically, 51% of global DAUs have already completed verification, with 65% completion in the United States — suggesting the drag is a one-time transition, not a structural crack. Meanwhile, users aged 18–34 drove a 50% engagement jump year-over-year, and Roblox is rewarding its developer community with a 42% increase in its Developer Exchange rate effective June 8, 2026. The pivot toward older, higher-spending demographics is a meaningful shift worth tracking through detailed sector analysis. The stock currently sits roughly 69% below its 52-week high of approximately $150, with full-year 2026 revenue growth guidance of 20%–25% still on the table.

Boston Scientific (BSX) reported 9% organic revenue growth in Q1 2026, but the market reacted sharply to the company cutting its full-year 2026 organic growth guidance to 6.5%–8% from an earlier target of 10%–11%. The headwinds are specific: unexpected market share loss in its FARAPULSE electrophysiology system (a device used to treat irregular heartbeats through a newer form of energy-based therapy), a mid-February dip in standalone WATCHMAN U.S. volumes (WATCHMAN is an implant that treats atrial fibrillation — an irregular heart rhythm — by sealing off a small pouch in the heart where dangerous clots form), and only 1% growth in its urology segment. However, WATCHMAN still grew 19% organically in Q1, and the company maintained its adjusted EPS (earnings per share — total profit divided by shares outstanding, a key profitability measure) guidance of $3.34–$3.41, reflecting 9%–11% growth. Its pending Penumbra acquisition is cited as a 2027-and-beyond growth catalyst, signaling that management is building the next chapter even as the current one faces some turbulence.

Key Companies and Supply Chain

Understanding where these three stocks sit within their broader sector analysis and supply chain context helps explain why short-term stumbles may not tell the full story.

ServiceNow (NOW — NYSE) operates entirely in the enterprise software space, where the supply chain is primarily intellectual capital: engineers, AI models, and deep integration partnerships across industries. Its Armis acquisition — referenced by the CFO on the Q1 2026 earnings call — strengthens its cybersecurity layer, while its AI platform positions it as the workflow automation backbone across healthcare, finance, and government. Competitors include Salesforce (CRM), SAP SE (SAP), and Oracle (ORCL), but Gartner's 2026 leadership designation suggests ServiceNow holds a clearly differentiated position. Investors are watching to see whether AI-driven enterprise demand continues expanding the company's total addressable market beyond its traditional IT service management roots.

Roblox (RBLX — NYSE) is a platform business — its supply chain runs through millions of independent game developers who build content on its infrastructure. The 42% Developer Exchange rate increase effective June 8, 2026, is designed to retain and attract top creators, which in turn drives user engagement and time-on-platform. Age-verification friction is largely a one-time regulatory adjustment; comparable platforms such as YouTube and Meta faced similar transitions and recovered their user trajectories. Roblox's market trends story now hinges on whether 18–34 year olds become consistent, high-spending users, and early data suggests momentum is building in that direction.

Boston Scientific (BSX — NYSE) operates across a complex medical device supply chain — specialized components, regulated manufacturing, hospital procurement relationships, and lengthy FDA approval timelines all factor into its growth pace. Its FARAPULSE and WATCHMAN devices both address the large and growing atrial fibrillation treatment market. The Penumbra acquisition expands its neurovascular footprint, which analysts suggest could become a meaningful revenue contributor by 2027. Direct competitors include Abbott Laboratories (ABT), Medtronic (MDT), and Johnson and Johnson MedTech (JNJ). Notably, the company's 9%–11% EPS growth guidance for 2026 remains intact despite the top-line revision — a signal that management is preserving profitability discipline even as it navigates product-level headwinds.

What Should You Do? 3 Action Steps

1. Build a Research Watchlist Before Moving

All three companies — ServiceNow, Roblox, and Boston Scientific — are worth adding to a personal research watchlist right now. Tracking their quarterly earnings, analyst rating revisions, and product-level updates over the next one to two quarters will help you form your own fact-based view on whether current price discounts reflect permanent damage or temporary noise. Solid investment research starts with patient data gathering, not reactive headline-chasing.

2. Examine the Specific Risk for Each Name

Not all sell-offs are created equal. For ServiceNow, the core risk is whether AI-driven enterprise software demand plateaus before the company can further expand its customer base. For Roblox, the risk is whether age-verification friction permanently caps user growth or proves to be a short-term speed bump. For Boston Scientific, the risk is whether FARAPULSE market share losses are recoverable and whether the urology segment reaccelerates. Understanding the specific risk — not just the headline price drop — is what separates rigorous stock analysis from reactive decision-making.

3. Think in Time Horizons That Match the Thesis

Goldman Sachs and 32 analysts see roughly 47% upside in ServiceNow — but that does not mean it materializes overnight. Roblox's older-demographic pivot may take two to three quarters to fully register in DAU numbers. Boston Scientific's Penumbra catalyst is explicitly framed as a 2027-and-beyond story. Aligning your personal time horizon with the investment thesis is a foundational step in any sector analysis framework. Always consult a licensed financial advisor before acting on any of this information — this article is educational only.

Frequently Asked Questions

Is ServiceNow (NOW) worth researching as a long-term investment after its 52% stock drop in 2026?

ServiceNow is drawing significant attention from analysts following its steep decline from its 52-week high of $211.48 to roughly $100. The company posted Q1 2026 total revenue of $3.77 billion — up 22% year-over-year — and raised its full-year subscription revenue guidance to $15.735B–$15.775B. With 32 Wall Street analysts maintaining a Buy rating and a consensus price target implying approximately 47% upside, it is a name that many investors are watching closely. Gartner also named it a 2026 leader in the Workplace Experience Application space, validating its competitive position. Whether it fits your personal financial situation is a question for a licensed financial professional — this is educational investment research only.

Why did Roblox stock drop 18% in May 2026 and could it recover over the next year?

Roblox fell more than 18% on May 1, 2026, after Q1 2026 daily active users came in at 132 million — below the 143.8 million Wall Street had expected. The shortfall was directly tied to friction from the mandatory age-verification rollout that launched in January 2026. Despite the DAU miss, revenue grew 39% year-over-year to $1.4 billion and bookings climbed 43% to $1.7 billion. With 51% of global users already verified, 65% completion in the U.S., and users aged 18–34 showing a 50% engagement increase year-over-year, some analysts view the sell-off as an overreaction worth researching further. The stock currently trades roughly 69% below its 52-week high of approximately $150.

What caused Boston Scientific to slash its 2026 revenue guidance and how serious is the long-term impact?

Boston Scientific trimmed its full-year 2026 organic revenue growth guidance to 6.5%–8% from an earlier target of 10%–11%. Three specific factors drove the revision: unexpected market share loss in its FARAPULSE electrophysiology system, a mid-February softening in standalone WATCHMAN U.S. volumes, and only 1% growth in its urology segment. Importantly, WATCHMAN still grew 19% organically in Q1, and adjusted EPS guidance of $3.34–$3.41 (representing 9%–11% profit growth) remains intact. The pending Penumbra acquisition is cited as a 2027-and-beyond growth catalyst, suggesting management views the current period as a product-cycle transition rather than a structural breakdown.

How is the 2026 AI software sell-off affecting enterprise SaaS stocks like ServiceNow and is it an opportunity?

The broader AI software sell-off that hit markets in early 2026 disproportionately impacted enterprise SaaS companies, including ServiceNow. Goldman Sachs noted in a May 2026 research note that the sell-off was overdone, arguing that enterprise leaders with durable revenue streams and accelerating AI-driven demand were punished well beyond what their fundamentals justified. For ServiceNow specifically, Q1 2026 results show no slowdown: 22% revenue growth, nearly 80% growth in large enterprise deal closings, 630 customers generating $5M+ in annual contract value, and a Gartner leadership designation all point to continued demand. Broader market trends suggest AI adoption in enterprise workflows is still in early stages, which is why investors and analysts continue to watch this space so closely.

What are the biggest risks to evaluate when researching growth stocks trading far below their 52-week highs in 2026?

Stocks that fall sharply sometimes represent genuine opportunity — and sometimes they fall further. The most important risks to evaluate during your own stock analysis include: whether the catalyst for the decline is temporary (like Roblox's age-verification friction) or structural (like a product permanently losing market share); whether the company's balance sheet and cash flow can sustain growth investment through a slow patch; and whether broader market trends — interest rates, sector rotation, macro conditions — are working for or against the category. Always treat published analysis, including this article, as a starting point for your own research, not a final conclusion. Speak with a licensed financial advisor before making any investment decisions.

Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security. Always do your own research and consult a licensed financial advisor before making investment decisions.

10 Best Dividend Growth Stocks to Watch Right Now: Investment Research Guide

Smart Investor Research is on NewsLens
Read all 22 AI channels in one free app

10 Best Dividend Growth Stocks to Watch in April 2025: Investment Research Guide

dividend growth portfolio sector analysis - black and silver laptop computer

Photo by Markus Winkler on Unsplash

Key Takeaways
  • The S&P 500 fell nearly 19% from its February 2025 peak after sweeping tariff announcements — but dividend growth stocks cushioned the blow significantly better than the broader market.
  • A top-10 high-growth dividend portfolio lost only 3.26% in March 2025, compared to SPY's 5.86% loss and VIG's 4.50% drop — a meaningful real-world outperformance.
  • Goldman Sachs projected a 6% rise in S&P 500 dividend payouts for full-year 2025, signaling that corporate earnings were broadly healthy enough to keep raising dividends even under tariff pressure.
  • The April 2025 high-growth dividend cohort traded at roughly 31% below estimated fair value, making several names worth researching for long-term total return potential.

What Happened

April 2025 was a stress test nobody ordered. The Trump administration's announcement of sweeping "reciprocal" tariffs on dozens of trading partners sent shockwaves through global markets. The S&P 500 fell nearly 19% from its February 2025 peak, briefly dipping below the 5,000 level for the first time since April 2024. For everyday investors, that kind of rapid decline can feel like a financial earthquake — the kind that triggers emotional selling and long-term regret.

But here is what the headline numbers missed: dividend growth stocks held up far better than the broader market. While market trends pointed toward panic, investors who owned high-quality dividend growers experienced a much smoother ride. A representative portfolio of the top 10 high-growth dividend stocks posted a loss of approximately 3.26% in March 2025, while the S&P 500 ETF (SPY) fell 5.86% and even the Vanguard Dividend Appreciation ETF (VIG) dropped 4.50%. That gap — roughly 2.6 percentage points versus SPY — is not a rounding error. Over time, those differences in drawdown compound into meaningful wealth preservation.

This kind of relative resilience is exactly why investment research into dividend growth strategies has gained renewed attention heading into the back half of 2025. When markets get choppy, companies that have the financial discipline to raise dividends year after year tend to be the ones with stronger balance sheets, more predictable cash flows, and better-managed operations. In volatile times, that consistency is worth paying close attention to.

What the Data Tells Us

The numbers behind the April 2025 dividend growth story reward careful stock analysis — and there are several layers worth unpacking.

Start with the macro picture. Goldman Sachs forecast a 6% increase in S&P 500 dividend payouts for full-year 2025, even as inflationary margin pressures squeezed sectors like Energy and Consumer Discretionary. That projection matters because it signals that corporate America was broadly generating enough free cash flow (money left over after paying operating costs and capital expenses) to keep returning capital to shareholders — even during a tariff-driven selloff.

Zoom into the sector analysis, and the data gets even more instructive. Excluding the Technology sector, the rest of the S&P 500 grew earnings by an average of 9.8% from Q1 through Q3 2025. That broad-based earnings growth is the underlying fuel that makes dividend sustainability possible. Companies can only reliably raise dividends if profits are growing underneath them — and by that measure, most of the market was in solid shape despite the volatility.

The April 2025 top-10 high-growth dividend list, as tracked by Seeking Alpha, carried an average dividend yield (annual dividend payment divided by share price) of approximately 1.25%. That may sound low compared to bonds or high-yield REITs, but that is intentional. Seeking Alpha contributors covering the cohort emphasized that the selection methodology "focuses on dividend growth and sustainability rather than high current yield," with final picks chosen based on sector diversity, high-growth quality scores, and positive momentum. These are stocks built for investors in the accumulation phase — people building wealth over time rather than drawing current income. The portfolio was assessed as roughly 31% undervalued relative to fair value estimates, representing a meaningful margin of safety (the gap between a stock's current price and its estimated true worth).

The Dividend Aristocrats — S&P 500 companies with 25 or more consecutive years of dividend increases — grew to 69 members as of early 2025, with three new additions: FactSet Research (FDS), Erie Indemnity (ERIE), and Eversource Energy (ES). These names carry an average dividend yield of 2.1% and represent the gold standard of dividend reliability, having maintained and grown their payouts through recessions, rate hike cycles, and multiple market crashes. For context on what that kind of consistency looks like in practice: Genuine Parts Company (GPC) declared its 69th consecutive annual dividend increase in February 2025 — a 3% raise. Sixty-nine years in a row. That track record tells investors something important about the company's financial culture and long-term discipline that no single quarterly earnings report can replicate.

Key Companies and Supply Chain

The sector analysis and supply chain positioning of these companies help explain why they appear on investor watchlists during periods of market stress — and what makes each one distinct.

ExxonMobil (XOM) — Energy
XOM yielded 3.3% in April 2025, with a 5-year annualized dividend growth rate of 2.3%. Its annual dividend of $3.96 per share is forecast to grow to $4.48 by 2028, according to analyst projections. As a vertically integrated energy major with exposure across the entire oil and gas supply chain — from upstream exploration and production to downstream refining, chemicals, and distribution — ExxonMobil has the operational scale to sustain dividends even through commodity price cycles. Investors are watching how tariff-driven energy cost shifts will affect margins in the years ahead.

Pfizer (PFE) — Healthcare
Pfizer yielded close to 7% in April 2025, making it one of the highest-yielding large-cap dividend growers on analyst watchlists. With a 5-year annualized dividend growth rate of 3.1%, Pfizer's pharmaceutical supply chain — spanning drug discovery, clinical manufacturing, and global distribution — provides a defensive income stream with global reach. Post-COVID revenue normalization has weighed on the share price, which is precisely why the yield looks elevated. The data suggests the dividend remains well-covered by operating cash flows, though ongoing stock analysis should track pipeline progress and cost structure.

Accenture (ACN) — Technology Services
Morningstar's April 2025 stock analysis placed Accenture at approximately 30% below its fair value estimate, with comprehensive AI-related service offerings cited as a key long-term growth driver. As enterprises accelerate digital transformation, Accenture occupies a critical position in the enterprise technology supply chain — the consulting and implementation layer that connects AI tools to real-world business operations. That positioning is increasingly difficult to replicate at scale.

PepsiCo (PEP) and Kimberly-Clark (KMB) — Consumer Staples
Morningstar analysts highlighted both companies as trading below fair value in April 2025, expecting mid-single-digit annual dividend growth going forward. Consumer staples businesses benefit from predictable demand regardless of broader market trends, making their dividends particularly durable across economic cycles. Investors are watching both as core accumulation-phase holdings.

Genuine Parts Company (GPC) — Industrials
With 69 consecutive years of dividend increases, GPC qualifies as a Dividend King (companies with 50 or more consecutive years of increases — an even rarer group than the Aristocrats). Its automotive and industrial parts distribution supply chain is deeply embedded in the U.S. economy, generating the steady, recurring cash flows that underpin its legendary dividend track record.

What Should You Do? 3 Action Steps

1. Screen for Dividend Growth Rate, Not Just Current Yield

High current yield can sometimes be a warning sign — it often means a stock's price has fallen because something is wrong with the business, a pattern sometimes called a "yield trap." Investment research consistently shows that companies with strong dividend growth rates (5% or more annually) tend to generate superior long-term total returns. Look for stocks with a history of consistent annual raises, a payout ratio (the percentage of earnings paid as dividends) below 60%, and earnings growth that can support future increases. The April 2025 high-growth cohort's average 1.25% yield paired with strong growth credentials is a useful model to study before building your own watchlist.

2. Benchmark Individual Stocks Against VIG Before Adding Them

The Vanguard Dividend Appreciation ETF (VIG) is a practical baseline for any dividend growth stock analysis. If individual stocks you are researching cannot plausibly outperform VIG over a full market cycle — including drawdowns like the March 2025 episode where VIG itself fell 4.50% — then the additional stock-picking complexity may not be worth the effort. Use VIG as your floor, not your ceiling, and only add individual names when your investment research reveals a compelling valuation or growth advantage over the index.

3. Use Market Selloffs as a Valuation Research Window

The April 2025 tariff-driven selloff temporarily pushed a high-quality dividend growth portfolio to roughly 31% below estimated fair value. Market corrections are historically when the most compelling long-term investment research opportunities emerge — not because you should try to catch a falling knife, but because valuations that were previously stretched suddenly become worth a closer look. Morningstar's fair value framework flagged Accenture (ACN) at approximately 30% below intrinsic value during this window. Building a watchlist of quality dividend growers in advance — so you know exactly what you want to own and at what price — is the key habit that separates reactive investors from prepared ones.

Frequently Asked Questions

Are dividend growth stocks a good investment to research during a market downturn in 2025?

Data from the April 2025 tariff-driven selloff suggests they can be a stabilizing force in a portfolio. A representative top-10 high-growth dividend portfolio lost approximately 3.26% in March 2025, compared to SPY's 5.86% loss — a meaningful gap in a short period. Dividend growth stocks tend to hold up better during drawdowns because companies with decades of consecutive dividend increases typically have stronger cash flows and more conservative financial management. That said, no investment strategy eliminates risk entirely, and investors are watching whether sustained tariff pressures could eventually affect corporate earnings and dividend sustainability in more cyclical sectors.

What is the difference between a high-yield dividend stock and a dividend growth stock — which is better for long-term wealth building?

A high-yield dividend stock pays a large percentage of its current price as dividends right now — think Pfizer's (PFE) close to 7% yield in April 2025. A dividend growth stock may start with a much lower yield (the April 2025 cohort averaged just 1.25%) but grows its payout consistently year after year. Over 10 to 20 years, a stock that raises its dividend 7% annually will eventually deliver a much higher "yield on cost" (your effective yield based on your original purchase price) than a static high-yield stock. For investors in the accumulation phase — building wealth rather than drawing income — dividend growth rate is generally the more important metric, which is why the Seeking Alpha methodology for the April 2025 list explicitly prioritized growth and sustainability over current yield.

How many Dividend Aristocrats are there in 2025 and how do I find the full list?

As of early 2025, there were 69 S&P 500 Dividend Aristocrats — companies with 25 or more consecutive years of dividend increases. Three new members were added in 2025: FactSet Research (FDS), Erie Indemnity (ERIE), and Eversource Energy (ES). The group carries an average dividend yield of 2.1%. You can find the current full list through S&P Global's index methodology page, or track them via the ProShares S&P 500 Dividend Aristocrats ETF (NOBL), which is designed to replicate their collective performance. The Dividend Kings — companies with 50 or more consecutive increases, like Genuine Parts Company (GPC) — are an even more exclusive subset worth researching separately.

Is Pfizer (PFE) a safe dividend stock to research in 2025 given its unusually high 7% yield?

Pfizer's approximately 7% yield in April 2025 puts it firmly in high-yield territory, which always warrants careful stock analysis. High yields can sometimes indicate that a dividend is at risk if earnings do not support it — a pattern known as a yield trap. In Pfizer's case, post-COVID revenue normalization has weighed on the share price, which mechanically pushes the yield higher even if the absolute payout has not changed. The 5-year annualized dividend growth rate of 3.1% and Pfizer's global pharmaceutical supply chain scale suggest the payout has underlying support, but investors are closely watching its drug pipeline, patent cliff exposure, and cost structure before drawing firm conclusions. This one is worth researching further with the most current earnings data and cash flow statements.

Which dividend growth stocks were most undervalued during the April 2025 market crash according to analysts?

Investment research from Morningstar and Seeking Alpha highlighted several names trading meaningfully below estimated fair value during the April 2025 tariff-driven selloff. Accenture (ACN) was flagged by Morningstar at approximately 30% below its fair value estimate, with AI-related professional services cited as a key long-term growth driver. PepsiCo (PEP) and Kimberly-Clark (KMB) were also highlighted by Morningstar analysts as trading below fair value, with expectations of mid-single-digit annual dividend growth going forward. Zooming out, the broader top-10 high-growth dividend cohort tracked by Seeking Alpha was assessed as roughly 31% undervalued in aggregate — a reminder that market trends during sharp corrections often create the research opportunities that patient, data-driven investors spend years waiting for.

Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security. Always do your own research and consult a licensed financial advisor before making investment decisions.

MNXT ETF Analyst Targets vs. Reality: A 15% Gap Worth Examining

Smart Investor Research is on NewsLens Read all 22 AI channels in one free app  App Store ▶ Google Play ...